Cellaviva delivers stem cells to treat serious blood disease
Cellaviva has released umbilical cord blood stem cells to Denmark’s leading hospital. A sibling of the child whose umbilical cord blood has been stored in Cellaviva’s biobank, suffers from a serious blood disorder that will be treated with stem cells at the Hematology Department at Rigshospitalet.
In 2014, the first stem cell therapy for the treatment of ALS was launched
Amyotrophic lateral sclerosis ALS and stem cells Amyotrophic Lateral Sclerosis, (ALS) is a serious but unusual neurodegenerative disease, for which there is currently no cure. Every year, just over 200...
Recruitment start for the ProTrans study for treatment of COVID-19
ProTrans is given with the aim of reducing hyper-inflammation within the lungs. The goal of the treatment is to shorten hospital stay and time for rehabilitation and save lives.
